Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Haematologica ; 99(5): 888-96, 2014 May.
Article in English | MEDLINE | ID: mdl-24362551

ABSTRACT

This work investigates the possibility that HLA-G, a molecule modulating innate and adaptive immunity, is part of an immune escape strategy of chronic lymphocytic leukemia cells. A 14 base pair insertion/deletion polymorphism (rs66554220) in the 3'-untranslated region of HLA-G influences mRNA stability and protein expression. The analysis of a cohort of patients with chronic lymphocytic leukemia confirmed that del/del individuals are characterized by higher levels of surface and soluble HLA-G than subjects with the other two genotypes. In line with its role in immunomodulation, the percentage of regulatory T lymphocytes is higher in del/del patients than in patients with the other genotypes and correlates with the amounts of surface or soluble HLA-G. Furthermore, addition of sHLA-G-rich plasma from patients with chronic lymphocytic leukemia induces natural killer cell apoptosis and impairs natural killer cell lysis, with effects proportional to the amount of soluble HLA-G added. Lastly, the presence of an HLA-G 14 base pair polymorphism is of prognostic value, with del/del patients showing reduced overall survival, as compared to those with other genotypes. These results suggest that: (i) the HLA-G 14 base pair polymorphism influences the levels of surface and soluble HLA-G expression, and (ii) the over-expression of HLA-G molecules contributes to creating tolerogenic conditions.


Subject(s)
HLA-G Antigens/genetics , HLA-G Antigens/immunology , Leukemia, Lymphocytic, Chronic, B-Cell/genetics , Leukemia, Lymphocytic, Chronic, B-Cell/immunology , Polymorphism, Genetic , Tumor Escape/genetics , Tumor Escape/immunology , Female , Gene Expression , HLA-G Antigens/metabolism , Humans , Immunophenotyping , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Leukemia, Lymphocytic, Chronic, B-Cell/mortality , Lymphocyte Count , Male , Prognosis , RNA, Messenger/genetics , RNA, Messenger/metabolism
2.
Hum Immunol ; 73(2): 150-5, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22178696

ABSTRACT

Human umbilical cord blood units (UCBs) are an alternative source in allogeneic-stem-cell transplantation. Human leukocyte antigen (HLA)-G is a tolerogenic molecule with a possible implication in UCB immunoregulatory effect. HLA-G expression was observed in UCB myeloid and plasmacytoid dendritic cells; in contrast, CD34(+) cells did not produce this molecule. CD34(+) cells are primitive hematopoietic progenitor cells that are present in UCB and are necessary for long-term engraftment via production of immunoregulatory molecules and a hematopoietic progeny that supports cellular recovery. The role of these cells in UCB transplantation needs further evaluation of HLA-G expression in CD34(+) cells and their hematopoietic progeny. We confirmed the absence of HLA-G expression in CD34(+) cells, whereas CD34(+)-derived progeny secreted HLA-G molecules and expressed HLA-G mRNA in in vitro cultures. Furthermore, soluble HLA (sHLA)-G molecules purified from the culture supernatants of CD34(+)-derived progeny were able to suppress lymphoproliferative response in an HLA-G dose-dependent manner. Overall these results identify CD34(+)-derived hematopoietic progeny as producers of HLA-G molecules and support a role of this antigen as an immuno-modulatory factor in UCB.


Subject(s)
Antigens, CD34/immunology , Fetal Blood/cytology , Fetal Blood/immunology , HLA-G Antigens/immunology , Adult , Cell Proliferation/drug effects , Cells, Cultured , Electrophoresis, Polyacrylamide Gel , Enzyme-Linked Immunosorbent Assay , Female , Gene Expression Regulation , HLA-G Antigens/isolation & purification , HLA-G Antigens/pharmacology , Humans , Immunologic Factors/pharmacology , Pregnancy
3.
Cytotherapy ; 13(5): 523-7, 2011 May.
Article in English | MEDLINE | ID: mdl-21171826

ABSTRACT

BACKGROUND AIMS: The beneficial activity of mesenchymal stromal cells (MSC) in allogeneic hematopietic stem cell transplantation requires correct use in terms of cell dose and timing of infusion and the identification of biomarkers for selection. The immunosuppressive bone marrow (BM)-derived MSC (BM-MSC) functions have been associated with the production of soluble HLA-G molecules (sHLA-G) via interleukin (IL)-10. We have established a reliable method for evaluating BM-MSC HLA-G expression without the influence of peripheral blood mononuclear cells (PBMC). METHODS: Thirteen BM-MSC from donors were activated with recombinant IL-10 or co-cultured with 10 different phytohemagglutinin (PHA)-treated PBMC (PHA-PBMC). Membrane-bound and sHLA-G expression was evaluated by flow cytometry and enzyme-linked immunosorbent assay (ELISA), respectively; lymphoproliferation was measured by (methyl-(3)H)thymidine. RESULTS: The results demonstrated the ability of IL-10 to stimulate both membrane-bound and sHLA-G production by BM-MSC. The levels of HLA-G expression induced by IL-10 in BM-MSC were associated with the inhibition of PHA-PBMC proliferation (sHLA-G, P = 0.0008, r = 0.9308; membrane HLA-G, P = 0.0005, r = 0.9502). CONCLUSIONS: We propose the evaluation of sHLA-G production in IL-10-treated BM-MSC cultures as a possible marker of immunoregulatory function.


Subject(s)
Bone Marrow Cells/immunology , Cell Separation/methods , HLA Antigens/analysis , Histocompatibility Antigens Class I/analysis , Immune Tolerance , Immunosuppression Therapy , Mesenchymal Stem Cells/immunology , Adult , Bone Marrow Cells/drug effects , Cells, Cultured , Coculture Techniques , HLA Antigens/biosynthesis , HLA-G Antigens , Histocompatibility Antigens Class I/biosynthesis , Humans , Interleukin-10/pharmacology , Leukocytes, Mononuclear/immunology , Lymphocyte Activation , Mesenchymal Stem Cells/drug effects , Middle Aged , Phytohemagglutinins/pharmacology , Stromal Cells/drug effects , Stromal Cells/immunology
4.
Cell Mol Life Sci ; 68(3): 433-51, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21080027

ABSTRACT

Following the Fifth International Conference on non-classical HLA-G antigens (HLA-G), held in Paris in July 2009, we selected some topics which focus on emerging aspects in the setting of HLA-G functions. In particular, HLA-G molecules could play a role in: (1) various inflammatory disorders, such as multiple sclerosis, intracerebral hemorrhage, gastrointestinal, skin and rheumatic diseases, and asthma, where they may act as immunoregulatory factors; (2) the mechanisms to escape immune surveillance utilized by several viruses, such as human cytomegalovirus, herpes simplex virus type 1, rabies virus, hepatitis C virus, influenza virus type A and human immunodeficiency virus 1 (HIV-1); and (3) cytokine/chemokine network and stem cell transplantation, since they seem to modulate cell migration by the downregulation of chemokine receptor expression and mesenchymal stem cell activity blocking of effector cell functions and the generation of regulatory T cells. However, the immunomodulatory circuits mediated by HLA-G proteins still remain to be clarified.


Subject(s)
HLA Antigens/immunology , Histocompatibility Antigens Class I/immunology , Animals , Cytokines/immunology , HLA-G Antigens , Humans , Immunologic Surveillance , Immunomodulation , Inflammation/immunology , Stem Cell Transplantation , Virus Diseases/immunology , Viruses/immunology
5.
J Clin Endocrinol Metab ; 95(7): 3342-6, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20427497

ABSTRACT

CONTEXT: Type 2 diabetes mellitus (T2DM) and obesity are characterized by a low-grade inflammation, which might be related to the development of insulin resistance. Human leukocyte antigen-G (HLA-G) shows antiinflammatory and tolerogenic properties, including the modulation of CD8+ T-cell cytotoxicity and regulation of CD4+ T-lymphocyte function. These functions are partially shared with IL-10, whose levels are reduced in insulin-resistant states. OBJECTIVE: The aim was to explore the relationship between HLA-G and the metabolic and inflammatory pattern of obesity or T2DM. PATIENTS AND MAIN OUTCOME MEASURES: Soluble HLA-G, IL-6, and IL-10 were measured and related with metabolic and biochemical parameters in 230 volunteers with normal glucose tolerance, impaired glucose tolerance, or T2DM by oral glucose tolerance test. RESULTS: sHLA-G, detected in 144 subjects (sHLA-G positive), was more frequent in T2DM or impaired glucose tolerance subjects than in normal glucose tolerance (chi(2) =18.6; P < 0.0001), and its plasma levels increased progressively across the classes of glucose tolerance. sHLA-G-positive individuals had higher body mass index, systolic blood pressure, and cholesterol levels; a reduced degree of insulin sensitivity; and almost 2-fold higher levels of IL-6, a cytokine related to insulin sensitivity, whereas IL-10 was similar. In the sHLA-G-positive subgroup, by a multivariate regression model, sHLA-G was significantly related to 2-h glucose, the area under insulin curve, and IL-6 levels (multiple r(2) = 0.14; P < 0.001), independently of age, gender, and body mass index. CONCLUSIONS: A frequent expression of sHLA-G, linked to a typical biomarker of insulin resistance like IL-6, seems to characterize subjects with an impaired glucose metabolism.


Subject(s)
Adiposity/physiology , Blood Glucose/metabolism , Diabetes Mellitus, Type 2/metabolism , Glucose Intolerance/metabolism , HLA Antigens/blood , Histocompatibility Antigens Class I/blood , Obesity/metabolism , Adult , Analysis of Variance , Biomarkers , Enzyme-Linked Immunosorbent Assay , Female , Glucose Intolerance/physiopathology , Glucose Tolerance Test , HLA-G Antigens , Humans , Insulin/blood , Interleukin-10/blood , Interleukin-6/blood , Male , Middle Aged , Obesity/physiopathology , Regression Analysis , Statistics, Nonparametric
6.
Hum Immunol ; 71(4): 342-50, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20097242

ABSTRACT

Human leukocyte antigen (HLA)-G molecules are nonclassical HLA class I antigens expressed as membrane bound and soluble isoforms (sHLA-G) with a restricted tissue distribution and anti-inflammatory functions. Because inflammation is involved in the pathogenesis of osteoarthritis (OA), we have analyzed the expression and production of HLA-G molecules in in vitro cultured synovial fibroblasts (SFs) from OA patients and control subjects. We have analyzed the levels of sHLA-G1 and HLA-G5 isoforms by immunoenzymatic assay (enzyme-linked immunosorbent assay) in the SF culture supernatants from six OA patients and six control subjects in 70-day in vitro cultures and after the addition of lipopolysaccharide or recombinant interleukin (IL)-10 (rIL-10). We have confirmed HLA-G modulation by cytofluorimetry and immunofluorescence. The results have demonstrated the spontaneous production of sHLA-G1 molecules by both OA and control SFs. The expression was confirmed by cytofluorimetry and immunofluorescence. OA SFs produce both sHLA-G1 and HLA-G5 molecules during the first 23 days of culture and higher levels of sHLA-G1 during the first 40 days of in vitro culture and after lipopolysaccharide or rIL-10 activation compared with control SFs. The production of HLA-G1 molecules, constitutively expressed by control and OA SFs, is significantly increased in OA, suggesting a possible mechanism to counteract the inflammation of the synovial joints.


Subject(s)
Fibroblasts/metabolism , HLA Antigens/metabolism , Histocompatibility Antigens Class I/metabolism , Osteoarthritis/immunology , Synovial Membrane/pathology , Aged , Aged, 80 and over , Cell Separation , Cells, Cultured , Female , Fibroblasts/immunology , Fibroblasts/pathology , Flow Cytometry , Fluorescent Antibody Technique , Gene Expression Regulation/immunology , HLA Antigens/genetics , HLA Antigens/immunology , HLA-G Antigens , Histocompatibility Antigens Class I/genetics , Histocompatibility Antigens Class I/immunology , Humans , Interleukin-10/immunology , Interleukin-10/metabolism , Lipopolysaccharides/immunology , Lipopolysaccharides/metabolism , Male , Middle Aged , Osteoarthritis/genetics , Osteoarthritis/metabolism , Osteoarthritis/pathology
7.
Acta Neurochir Suppl ; 106: 141-5, 2010.
Article in English | MEDLINE | ID: mdl-19812937

ABSTRACT

Serum levels of sHLA-G (sHLA-G1/HLA-G5) antigens and their soluble isoforms, sHLA-G1 and HLA-G5, were measured by ELISA in 22 patients with spontaneous intracerebral hemorrhage (SICH) at 24 h, 48 h and 7 days after bleeding. The perihematomal edema volume was calculated on non-enhanced computed tomography scans using the formula AxBxC/2 at the same time points. The mean serum concentrations of sHLA-G1/HLA-G5 and sHLA-G1 as well as the perihematomal edema volume changed significantly over time (p < 0.0001, p < 0.001 and p < 0.0001, respectively), whereas no statistical differences were found in serum HLA-G5 concentrations over the course of the experiment. In comparison to the values found at 24 h, sHLA-G1/HLA-G5 and sHLA-G1 increased at 48 h and then decreased at 7 days, whereas the perihematomal edema volume was more elevated at 48 h and, to a lesser extent, at 7 days. A positive correlation was detected between mean serum sHLA-G1/HLA-G5 and sHLA-G1 levels and perihematomal edema volume at 24 h (p < 0.02) and at 48 h (p < 0.01). Our results may indicate a role for sHLA-G in inflammatory mechanisms related to SICH, where these proteins probably act as anti-inflammatory molecules and are predominantly produced as the sHLA-G1 isoform.


Subject(s)
Cerebral Hemorrhage/blood , HLA Antigens/blood , Histocompatibility Antigens Class I/blood , Aged , Aged, 80 and over , Analysis of Variance , Brain Edema/etiology , Cerebral Hemorrhage/complications , Cerebral Hemorrhage/diagnostic imaging , Enzyme-Linked Immunosorbent Assay/methods , Female , HLA-G Antigens , Humans , Male , Middle Aged , Time Factors , Tomography, X-Ray Computed/methods
8.
Am J Reprod Immunol ; 62(5): 320-38, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19811467

ABSTRACT

PROBLEM: Human Leukocyte Antigen (HLA)-G is a class Ib gene located in the human major histocompatibility complex (MHC). Several lines of investigation indicate that the HLA-G molecule is involved in the maternal acceptance of the semi-allogenic fetus during pregnancy and in the development of tolerance. Expression of soluble HLA-G (sHLA-G) is positively correlated with successful in vitro fertilization (IVF) treatments, and aberrant expression of HLA-G in certain complications of pregnancy, such as pre-eclampsia and spontaneous abortion, has been reported. The main purpose of this study was to investigate the levels of different soluble HLA-G isoforms in maternal plasma in early and late pregnancy. METHOD OF STUDY: Soluble HLA-G (sHLA-G) can be detected in maternal blood, and in this study, two different isoforms of sHLA-G, namely sHLA-G1 generated by shedding of membrane-bound HLA-G1 and HLA-G generated by specific HLA-G transcripts, have been investigated early [median of 16.4 weeks of gestation (GW)] and late (median: 38.9 GW) in pregnancy in an original cohort of 580 pregnant Caucasian women. RESULTS: Lower concentrations of sHLA-G1 were found late in pregnancy (>32 GW) in a group of women with severe pre-eclampsia compared with controls with uncomplicated pregnancies (P = 0.029, P(C) = 0.09; Mann-Whitney; Logistic regression analysis: P = 0.024, OR = 0.920, 95% CI: 0.855-0.989). However, this was not the case with HLA-G5, and significantly more of the cases with severe pre-eclampsia had detectable plasma HLA-G5 compared with that of the control group (P = 0.013, P(C) = 0.04; Mann-Whitney). Similar findings were not observed in women with gestational hypertension or existing hypertension continuing into pregnancy. Furthermore, there was a trend toward lower maternal plasma sHLA-G1 in a group of women with premature birth (<37 GW) compared with that of the control group (P = 0.028, P(C) = 0.17; Mann-Whitney). On the contrary, HLA-G5 was lower in the control group compared with that in the premature group (P = 0.004, P(C) = 0.02; Mann-Whitney). CONCLUSION: This study shows in line with other published studies that a high, detectable soluble HLA-G concentration in maternal plasma or serum is not mandatory for a successful pregnancy. However, complications during pregnancy, such as (severe) pre-eclampsia, spontaneous abortion, IUGR, and premature birth, are associated with a low or undetectable level of soluble HLA-G in the maternal blood circulation. Also, this study indicates that sHLA-G1 is the interesting soluble HLA-G isoform in pre-eclampsia, and that low or undetectable levels of HLA-G5 at the end of pregnancy seem to be associated with an uncomplicated normal pregnancy, whereas in severe pre-eclampsia and possibly other pregnancy complications, such as preterm birth and IUGR, the level of HLA-G5 is higher.


Subject(s)
HLA Antigens/metabolism , Histocompatibility Antigens Class I/metabolism , Hypertension/immunology , Pre-Eclampsia/immunology , Pregnancy Complications, Cardiovascular/immunology , Premature Birth/immunology , Adult , Cohort Studies , Female , Gene Expression Regulation , Gestational Age , HLA Antigens/genetics , HLA Antigens/immunology , HLA-G Antigens , Histocompatibility Antigens Class I/genetics , Histocompatibility Antigens Class I/immunology , Humans , Hypertension/blood , Hypertension/physiopathology , Immune Tolerance , Pre-Eclampsia/blood , Pre-Eclampsia/physiopathology , Pregnancy , Pregnancy Complications, Cardiovascular/blood , Pregnancy Complications, Cardiovascular/physiopathology , Premature Birth/blood , Premature Birth/physiopathology , Time Factors
9.
Int J Mol Med ; 24(4): 523-30, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19724893

ABSTRACT

Oocyte selection with the highest competence is a major goal in IVF. Several studies demonstrated that non-classical HLA class I HLA-G molecule modulation creates a tolerogenic microenvironment at the feto-maternal interface and is implicated in embryo implantation. This study investigated if soluble HLA-G molecules producted by the cumulus-oocyte complex (COC) are markers of oocyte maturation. sHLA-G molecule levels were analyzed using Bio-Plex assay in 152 COC supernatants obtained from 42 women and maturated by an 'in vitro maturation procedure'. The presence of sHLA-G molecules was confirmed by Western blotting technique. The results demonstrate detectable amounts of sHLA-G molecules ranging from 300 to 800 pg/ml in 14/73 (19%) COCs that generated mature oocytes and complete absence of detectable sHLA-G antigens in the supernatants of COCs that corresponded to immature oocytes. The detection of sHLA-G molecules in the COC culture supernatants corresponding to matured oocytes is proposed to be a marker to identify gametes with higher functionality. This non-invasive marker could be used, in addition to morphological approaches, to reduce the number of fertilized oocytes and transferred embryos.


Subject(s)
Cumulus Cells/cytology , Cumulus Cells/metabolism , HLA Antigens/metabolism , Histocompatibility Antigens Class I/metabolism , Oocytes/cytology , Oocytes/metabolism , Adult , Blotting, Western , Cells, Cultured , Enzyme-Linked Immunosorbent Assay , Female , Fertilization in Vitro , HLA-G Antigens , Humans
10.
J Immunol ; 183(7): 4302-11, 2009 Oct 01.
Article in English | MEDLINE | ID: mdl-19748989

ABSTRACT

Bacterial LPS induces the release of ATP from immune cells. Accruing evidence suggests that extracellular ATP participates in the inflammatory response as a proinflammatory mediator by activating the inflammasome complex, inducing secretion of cytokines (IL-1, IL-18) and cell damaging agents such as oxygen radicals, cationic proteins, and metalloproteases. It is not known whether ATP can also act as a proinflammatory mediator by inhibiting production of molecules down-modulating the immune response. Here, we show that extracellular ATP impairs in an IL-10-dependent fashion the expression of the tolerogenic soluble and membrane-bound HLA-G Ag in human monocytes. The effect of ATP was mimicked by BzATP (3'-O-(4-benzoyl)benzoyl-ATP) and greatly reduced by pretreatment with oATP (periodate-oxidized ATP), KN-62 (1-[N,O-bis(5-isoquinoline-sulfonyl)-N-methyl-l-tyrosyl]-4-phenylpiperazine), and an anti-P2X(7) mAb, thus pointing to a specific role of the P2X(7) receptor. The effect of ATP was time- and dose-dependent and was not due to a decrease in expression of IL-10 receptor. Inhibition by ATP was reverted by supplementation of culture medium with exogenous IL-10. Due to the well-known immunosuppressive activity of IL-10 and soluble HLA-G, this novel effect of ATP might be relevant for the pathophysiology and therapy of inflammatory disorders.


Subject(s)
Down-Regulation/immunology , Extracellular Space/immunology , HLA Antigens/immunology , HLA Antigens/metabolism , Histocompatibility Antigens Class I/immunology , Histocompatibility Antigens Class I/metabolism , Inflammation Mediators/physiology , Monocytes/immunology , Monocytes/metabolism , Receptors, Purinergic P2/metabolism , Cell Line, Tumor , Cell Membrane/immunology , Cell Membrane/metabolism , Cells, Cultured , Extracellular Space/metabolism , HLA Antigens/biosynthesis , HLA-G Antigens , Histocompatibility Antigens Class I/biosynthesis , Humans , Inflammation Mediators/metabolism , Interleukin-10/antagonists & inhibitors , Interleukin-10/biosynthesis , Interleukin-10/metabolism , Lipopolysaccharides/blood , Receptors, Purinergic P2/physiology , Receptors, Purinergic P2X7
11.
Hum Immunol ; 70(12): 981-7, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19651179

ABSTRACT

Nonclassical human leukocyte antigen (HLA)-G antigens in soluble form (sHLA-G) have recently been suggested to have a potential role as immunomodulatory factors in multiple sclerosis (MS), a chronic inflammatory demyelinating and neurodegenerative disease of the central nervous system of unknown etiology and supposed autoimmune origin. In MS patients, sHLA-G levels were elevated in cerebrospinal fluid (CSF), intrathecally synthesized, predominantly represented by the HLA-G5 isoform and even more elevated in cases of inactive disease, as determined by magnetic resonance imaging. In MS, CSF sHLA-G concentrations were also related to the formation of an intrathecal anti-inflammatory microenvironment based on a positive correlation to CSF interleukin-10 titers and an inverse association to the levels of antiapoptotic sFas molecules in the CSF. Expression of HLA-G antigens was detected in microglia, macrophages, and endothelial cells within and around MS lesions and was enhanced in microglial cells by T-helper-1 proinflammatory cytokines. A novel subpopulation of naturally occurring CD4(+) and CD8(+) regulatory T cells expressing HLA-G1 and secreting HLA-G5 was identified in the CSF of MS patients. Taken together, these findings seem to indicate that sHLA-G antigens may be implicated in the termination of MS autoimmunity and associated with remission of the disease through their function as anti-inflammatory molecules. However, the mechanisms operating in the immunomodulatory circuit mediated by sHLA-G proteins remain to be clarified.


Subject(s)
HLA Antigens/immunology , Histocompatibility Antigens Class I/immunology , Multiple Sclerosis/immunology , T-Lymphocyte Subsets/immunology , Autoimmunity/immunology , HLA Antigens/cerebrospinal fluid , HLA-G Antigens , Histocompatibility Antigens Class I/cerebrospinal fluid , Humans , Interleukin-10/cerebrospinal fluid , Multiple Sclerosis/physiopathology , fas Receptor/cerebrospinal fluid
12.
Hum Immunol ; 70(12): 970-5, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19654031

ABSTRACT

Human leucocyte antigen-G (HLA-G) is a nonclassical HLA class I molecule observed for the first time in human cytotrophoblast. Several investigations have demonstrated the presence of soluble HLA-G in oocyte/embryo secretome. A focus on the possible role of HLA-G in oocyte/embryo context will be developed in this review. In addition, the possible use of HLA-G in assisted reproductive technology will be treated.


Subject(s)
Embryo, Mammalian/metabolism , Follicular Fluid/metabolism , HLA Antigens/metabolism , Histocompatibility Antigens Class I/metabolism , Oocytes/metabolism , Receptors, Immunologic/metabolism , Embryo, Mammalian/immunology , Female , Follicular Fluid/immunology , HLA Antigens/immunology , HLA-G Antigens , Histocompatibility Antigens Class I/immunology , Humans , Maternal-Fetal Relations , Oocytes/immunology , Receptors, Immunologic/immunology , Receptors, KIR2DL5
13.
Am J Reprod Immunol ; 61(5): 368-76, 2009 May.
Article in English | MEDLINE | ID: mdl-19341387

ABSTRACT

PROBLEM: HLA-G antigen maintains a tolerogenic condition at the foeto-maternal interface, counteracts inflammation in autoimmune diseases and soluble HLA-G (sHLA-G) levels decrease in allergic-asthmatics. Taking into consideration these findings, we analyzed if sHLA-G and interleukin-10 (IL-10) could be influenced by pregnancy and labour in allergic and non-allergic women. METHOD OF STUDY: sHLA-G isoforms and IL-10 levels were determined in the plasma samples of 43 women (15 non-allergic, 28 allergic) during third trimester, at delivery and 2 years after pregnancy by immunoenzymatic assays. RESULTS: A significant increase in sHLA-G and IL-10 levels was documented at delivery in both allergic and non-allergic women. Allergic women showed lower sHLA-G concentrations. sHLA-G1 was evidenced as the predominant plasma isoform. CONCLUSION: The data showed increased sHLA-G and IL-10 concentrations at delivery, regardless of the allergic status. The sHLA-G1 isoform is mainly responsible for the increased sHLA-G levels at delivery.


Subject(s)
HLA Antigens/blood , Histocompatibility Antigens Class I/blood , Hypersensitivity/blood , Hypersensitivity/immunology , Interleukin-10/blood , Labor Onset/immunology , Adult , Female , Follow-Up Studies , HLA-G Antigens , Humans , Labor Onset/blood , Pregnancy
15.
Cytometry B Clin Cytom ; 76(3): 225-30, 2009 May.
Article in English | MEDLINE | ID: mdl-18985728

ABSTRACT

Biologic and clinical interest in human mesenchymal stromal cells (hMSC) has risen over the last years, mainly due to their immunosuppressive properties. In this study, we investigated the basis of immunomodulant possible variability using hMSC from different sources (amniotic membrane, chorion, and bone marrow from either healthy subjects or patients with hematological malignancies, HM) and having discordant positivity for several immunological markers. The CD90+ hMSC reduced lymphoproliferative response in phytohemagglutinin (PHA) activated peripheral blood mononuclear cells (PBMC) via sHLA-G and IL-10 up-modulation. On the contrary, hMSC showing a significantly lower expression for CD90 antigen, elicited a lymphoproliferative allogeneic response in PHA/PBMCs without any increase in soluble HLA-G and IL-10 levels. These data seems to suggest that CD90 molecule may be considered a novel predictive marker for hMSC inhibitory ability, and might cooperate with HLA-G molecule in regulating suppressive versus stimulatory properties of hMSC. These results may have clinical implication in either transplantation or in regenerative medicine fields.


Subject(s)
Immune Tolerance/immunology , Mesenchymal Stem Cells/immunology , Mesenchymal Stem Cells/metabolism , Thy-1 Antigens/analysis , Thy-1 Antigens/metabolism , Adult , Cells, Cultured , Coculture Techniques , Female , Flow Cytometry , HLA Antigens/immunology , HLA-G Antigens , Histocompatibility Antigens Class I/immunology , Humans , Male , Middle Aged , Thy-1 Antigens/immunology
16.
Environ Toxicol Pharmacol ; 27(2): 303-5, 2009 Mar.
Article in English | MEDLINE | ID: mdl-21783957

ABSTRACT

HLA-G antigens are non-classical HLA-class I anti-inflammatory molecules. Since styrene exposure has been suggested to induce immune alteration, we analyzed plasma levels and "in vitro" peripheral blood mononuclear cell (PBMC) production of soluble HLA-G (sHLA-G) and interleukin-10 (IL-10) molecules after lipopolysaccharide (LPS) stimulation, in styrene exposed workers and healthy subjects. Exposed workers showed reduced plasma levels of sHLA-G and IL-10 in comparison to healthy controls. Similarly, lower levels of sHLA-G and IL-10 molecules were observed in PBMC culture supernatants after LPS activation. These data propose styrene exposure as a mediator of impaired sHLA-G production.

17.
PLoS One ; 3(12): e3970, 2008.
Article in English | MEDLINE | ID: mdl-19092999

ABSTRACT

BACKGROUND: During the last years, several studies have reported the significant relationship between the production of soluble HLA-G molecules (sHLA-G) by 48-72 hours early embryos and an increased implantation rate in IVF protocols. As consequence, the detection of HLA-G modulation was suggested as a marker to identify the best embryos to be transferred. On the opposite, no suitable markers are available for the oocyte selection. METHODOLOGY/PRINCIPAL FINDINGS: The major finding of the present paper is that the release of ICAM-1 might be predictive of oocyte maturation. The results obtained are confirmed using three independent methodologies, such as ELISA, Bio-Plex assay and Western blotting. The sICAM-1 release is very high in immature oocytes, decrease in mature oocytes and become even lower in in vitro fertilized embryos. No significant differences were observed in the levels of sICAM-1 release between immature oocytes with different morphological characteristics. On the contrary, when the mature oocytes were subdivided accordingly to morphological criteria, the mean sICAM-I levels in grade 1 oocytes were significantly decreased when compared to grade 2 and 3 oocytes. CONCLUSIONS/SIGNIFICANCE: The reduction of the number of fertilized oocytes and transferred embryos represents the main target of assisted reproductive medicine. We propose sICAM-1 as a biochemical marker for oocyte maturation and grading, with a possible interesting rebound in assisted reproduction techniques.


Subject(s)
Embryo, Mammalian/metabolism , Fertilization in Vitro , Intercellular Adhesion Molecule-1/metabolism , Oocytes/metabolism , Adult , Biomarkers/metabolism , Cells, Cultured , Chemokines/metabolism , Culture Media, Conditioned/chemistry , Cytokines/metabolism , Embryo, Mammalian/cytology , Female , HLA Antigens/metabolism , HLA-G Antigens , Histocompatibility Antigens Class I/metabolism , Humans , Intercellular Adhesion Molecule-1/analysis , Oocytes/physiology , Oogenesis/physiology , Pregnancy , Pregnancy Rate , Quality Control , Solubility
18.
Am J Rhinol ; 22(5): 468-73, 2008.
Article in English | MEDLINE | ID: mdl-18954504

ABSTRACT

BACKGROUND: Sinonasal polyposis (SNP) is a chronic inflammatory pathology of nasal and paranasal cavities. Human leukocyte antigen (HLA) G molecules are nonclassic class I antigens with anti-inflammatory and tolerogenic properties. As most theories consider polyps to be the manifestation of chronic inflammation, there could be a possible implication of HLA-G molecules in SNP. The purpose of this study was to investigate the possible correlation between SNP and the production of soluble HLA-G (sHLA-G) by peripheral blood mononuclear cells (PBMCs). METHODS: The study involved 22 SNP patients (11 with no evidence of disease [NED] after surgery and 11 with relapse [RE]) and 20 healthy subjects. The presence of sHLA-G in PBMC lipopolysaccharide (LPS)-stimulated culture supernatants was analyzed. The levels of interleukin (IL) 10, one of the main up-regulators of sHLA-G production, were determined. Exogenous IL-10 was added to the SNP PBMC cultures to reconstitute the impairment in sHLA-G production. RESULTS: Increased IL-10 levels in LPS-activated PBMC culture supernatants were found in NED patients in comparison with healthy subjects (p = 0.0184). No sHLA-G production was observed in either of the patient subgroup supernatants (p < 0.0001). The addition of exogenous IL-10 showed the reconstitution of sHLA-G production in NED and in a lower amount in RE patients. CONCLUSION: The results show a defect in sHLA-G production in SNP patients mainly related to the IL-10/HLA-G pathway. Given the anti-inflammatory functions of HLA-G molecules, this impairment could increase the susceptibility to the disease. The different sHLA-G production after exogenous IL-10 addition between NED and RE SNP could represent a marker of disease severity.


Subject(s)
HLA Antigens/biosynthesis , Histocompatibility Antigens Class I/biosynthesis , Nasal Polyps/immunology , Paranasal Sinus Diseases/immunology , Cells, Cultured , Female , Flow Cytometry , Follow-Up Studies , HLA Antigens/immunology , HLA-G Antigens , Histocompatibility Antigens Class I/immunology , Humans , Immunoassay , Interleukin-10/biosynthesis , Leukocytes, Mononuclear/metabolism , Leukocytes, Mononuclear/pathology , Male , Middle Aged , Nasal Polyps/metabolism , Nasal Polyps/pathology , Paranasal Sinus Diseases/metabolism , Paranasal Sinus Diseases/pathology , Retrospective Studies , Severity of Illness Index
19.
Arch Dermatol Res ; 300(10): 551-9, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18797896

ABSTRACT

Human leukocyte antigen (HLA)-G is a non-classical HLA class I molecule that exerts a generalized immunosuppressive action. A deficit in membrane bound and soluble HLA-G levels seems to cause a defective control on immune responses and trigger off several autoimmune diseases. As psoriasis is considered an autoimmune disease, lower levels of soluble HLA-G (sHLA-G) might be expected in psoriatic patients than in healthy controls. The aims of this descriptive study were: (1) to evaluate whether sHLA-G levels are different in psoriatic patients compared to controls; (2) to compare sHLA-G levels between groups of patients treated with different therapies; (3) to evaluate whether any differences found in HLA-G expression could be related to a genetic control. Peripheral blood samples were investigated for sHLA-G and IL-10 levels and for HLA-G 14 bp polymorphism in 65 patients with moderate-to-severe plaque psoriasis treated with systemic drugs or with topical or physical treatments and in controls. Significantly lower plasma levels of both sHLA-G and IL-10 were found in psoriatic group compared to controls and in local treated patients in comparison with systemic treated patients. These findings could indicate that low sHLA-G levels may contribute to susceptibility to psoriasis. Absence of differences in HLA-G 14 bp allele and genotype frequencies between psoriatic patients and controls and between patients following different treatments seems to exclude genetic bases of sHLA-G levels. It could be speculated that therapeutics antagonizing systemic T helper 1 activation may induce sHLA-G secretion via an IL-10-dependent pathway.


Subject(s)
HLA Antigens/blood , Histocompatibility Antigens Class I/blood , Immune System/physiopathology , Interleukin-10/blood , Psoriasis/blood , Acitretin/therapeutic use , Adult , Aged , Aged, 80 and over , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Humanized , Case-Control Studies , Cross-Sectional Studies , Cyclosporine/therapeutic use , Dermatologic Agents/therapeutic use , Female , Gene Frequency/genetics , Genotype , HLA-G Antigens , Humans , Immune System/pathology , Male , Middle Aged , Polymorphism, Genetic/genetics , Psoriasis/drug therapy , Psoriasis/genetics , T-Lymphocytes/pathology , Young Adult
20.
Inflamm Allergy Drug Targets ; 7(2): 67-74, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18691135

ABSTRACT

HLA-G antigens are non classical HLA-class I molecules characterized by a low allelic polymorphism, a limited tissue distribution and the presence of membrane bound and soluble isoforms. The HLA-G antigens were firstly detected in cytotrophoblast cells at the feto-maternal interface where they maintain a tolerogenic status between the mother and the semiallogenic fetus. Recently a variable expression of HLA-G molecules has been documented in several autoimmune diseases, viral infections, cancer diseases and transplantation. Overall the presence of HLA-G molecules in both membranes bound and soluble isoforms was associated with tolerogenic functions against innate and adaptative cellular responses. HLA-G antigens are able to affect the cytotoxicity of natural killer and CD8+ T cells, CD4+ T lymphocyte functions and dendritic cell maturation. In addition to the allelic polymorphism the HLA-G gene shows a deletion/insertion polymorphism of a 14 base pairs sequence (14bp) in the exon 8 at the 3' untranslated region. Several reports have associated the presence of the 14bp insertion allele (+14bp) to an unstable mRNA and a lower sHLA-G protein production, suggesting a different ability to counteract inflammation between genotypes. We reviewed the literature on the expression of HLA-G antigens in autoimmune and allergic diseases and the possible functional role of these molecules in counteracting inflammation.


Subject(s)
HLA Antigens/immunology , Histocompatibility Antigens Class I/immunology , Immune Tolerance/immunology , Inflammation/immunology , Lymphocyte Subsets/immunology , Trophoblasts/immunology , Alleles , Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/metabolism , Asthma/immunology , Asthma/metabolism , Central Nervous System/immunology , Central Nervous System/metabolism , Exons , Gastrointestinal Diseases/immunology , Gastrointestinal Diseases/metabolism , HLA Antigens/blood , HLA Antigens/genetics , HLA Antigens/metabolism , HLA-G Antigens , Histocompatibility Antigens Class I/blood , Histocompatibility Antigens Class I/genetics , Histocompatibility Antigens Class I/metabolism , Humans , Inflammation/metabolism , Lymphocyte Subsets/metabolism , Protein Isoforms/immunology , Protein Isoforms/metabolism , RNA, Messenger/immunology , RNA, Messenger/metabolism , Skin/immunology , Skin/metabolism , Trophoblasts/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...